Fresno, C. d., Fresno, C. d., García-Arriaza, J., Martínez-Cano, S., Martínez-Cano, S., Heras-Murillo, I., . . . Sancho, D. (2021). The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity. Frontiers Media S.A.
Chicago Style (17th ed.) CitationFresno, Carlos del, et al. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationFresno, Carlos del, et al. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity. Frontiers Media S.A, 2021.
Warning: These citations may not always be 100% accurate.